Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant adenovirus vectored FMDV vaccines and uses thereof

Recombinant adenovirus vectored FMDV vaccines and uses thereof

US Patent 10188721 · Granted Jan 29, 2019

Estimated economic value: $58,243,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Human papillomavirus vaccines and uses of the same2025
Hepatitis B vaccines and uses of the same2025
Hepatitis B vaccines and uses of the same2023
Simian (gorilla) adenovirus or adenoviral vectors and methods of use2022
Simian (gorilla) adenovirus or adenoviral vectors and methods of use2022
Simian (gorilla) adenovirus or adenoviral vectors and methods of use2022
Adenoviral vector encoding human atonal homolog-1 (HATH1)2022
Adenoviral vector encoding human atonal homolog-1 (HATH1)2022
Adenovectors for delivery of therapeutic genetic material into T cells2021
Adenovectors for delivery of therapeutic genetic material into T cells2021
Affenadenovirus (gorilla) or adenoviral vectors and methods of use2021
Affenadenovirus (gorilla) or adenoviral vectors and methods of use2021